Cryptococcosis in HIV-negative Patients with Renal Dialysis: A Retrospective Analysis of Pooled Cases

Nan Hong1, Min Chen1, Wenjie Fang1

  • 1Shanghai Key Laboratory of Molecular Medical Mycology, Department of Dermatology, Changzheng Hospital, Second Military Medical University, Shanghai, China.

Mycopathologia
|July 2, 2017
PubMed

Insights

Cryptococcosis in HIV-negative dialysis patients is poorly understood. This study highlights non-neoformans/gattii species and suggests considering cryptococcosis even with negative antigen tests, emphasizing catheter removal and optimized antifungal strategies.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Nephrology

Background:

  • Cryptococcosis, a serious fungal infection, is primarily caused by Cryptococcus neoformans/C. gattii.
  • Data on cryptococcosis in HIV-negative patients undergoing renal dialysis is limited.
  • Understanding this infection in dialysis patients is crucial for timely diagnosis and treatment.

Purpose of the Study:

  • To systematically review the epidemiology and clinical features of cryptococcosis in HIV-negative patients on renal dialysis.
  • To pool data from multiple sources to increase statistical power and provide a comprehensive overview.
  • To identify specific challenges and recommendations for managing cryptococcosis in this vulnerable population.

Main Methods:

  • A pooled analysis of 18 cases from the authors' hospital and four medical databases.
  • Analysis of epidemiological data, including dialysis modality and duration.
  • Review of clinical manifestations and causative fungal species.

Main Results:

  • The median dialysis duration was 8 months for peritoneal dialysis and 36 months for hemodialysis.
  • Non-neoformans/gattii species, such as Cryptococcus laurentii and Cryptococcus albidus, were identified.
  • Clinical presentations of these non-neoformans/gattii species were similar to those of C. neoformans and C. gattii.

Conclusions:

  • Physicians should suspect cryptococcosis in renal dialysis patients, even with negative cryptococcal antigen tests.
  • Prompt catheter removal is vital for peritoneal dialysis patients diagnosed with cryptococcosis.
  • Optimized antifungal treatment strategies are needed for renal dialysis recipients with cryptococcal infections.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.0K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
795
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
286
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
654
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
387